172
Participants
Start Date
December 31, 2010
Primary Completion Date
July 31, 2014
Study Completion Date
August 31, 2014
Bosutinib
Once daily oral dose of 200 mg of bosutinib
Bosutinib
Once daily oral dose of 400 mg of bosutinib transitioned to 200 mg/day
Placebo
Once daily oral dose of placebo
PRA Magyarorszag Kft. Klinikai Farmakologiai Vizsgalohely, Budapest
Fovarosi Onkormanyzat Szent Imre Korhaz BSZMI Klinikai Farmakologiai Reszlege, Budapest
Spitalul Clinic Republican, Chisinau
Monash Medical Centre, Clayton
Szegedi Tudomanyegyetem, AOK, Szent-Gyorgyi Albert Klinikai Kozpont I.sz.Belgyogyaszati Klinika, Szeged
Universitaetsspital Zuerich, Zurich
New York University - HHC CTSI Clinical Research Center, New York
Doylestown Hospital MRI, Doylestown
Doylestown Hospital, Doylestown
Nephrology/Hypertension Specialists, Doylestown
University of Virginia Health System - Nephrology, Charlottesville
University of Virginia Health System, Charlottesville
Istituti Ospitalieri di Cremona, Cremona
Istanbul University, Istanbul Tip Fakultesi, Istanbul
Dokuz Eylul Universitesi Hastanesi Ic Hastaliklari Anabilim Dali, Izmir
Washington University School of Medicine, St Louis
Washington University, St Louis
Renal Associates of Baton Rouge, Baton Rouge
A.O. Universitaria Ospedali Riuniti di Foggia, Foggia
Renal Associates, PA, San Antonio
San Antonio Kidney Disease Center Physicians Group, P.L.L.C., San Antonio
Univerzitna nemocnica Bratislava, Limbova 5
Boise Kidney & Hypertension Institute, PLLC, Caldwell
Boise Kidney & Hypertension Institute, PLLC, Meridian
Southwest Kidney Institute, PLC, Phoenix
Southwest Clinical Research Institute, LLC, Tempe
Southwest Kidney Institute, PLC, Tempe
Capital Nephrology Clinical Research, Sacramento
The Polyclinic, Seattle
Renal Remission and Hypertension Clinic, Silverdale
SPITALUL CLINIC JUDETEAN DE URGENTA TIMISOARA ,Clinica de Nefrologie, Timișoara
Spitalul Clinic Municipal Dr. Gavril Curteanu Oradea, Oradea
Spitalul Clinic Dr. C. I. Parhon Iasi, Iași
Tufts Medical Center, Boston
Toronto General Hospital, Toronto
Hopital du Sacre-Coeur de Montreal, Montreal
Klinika gerontologicka a metabolicka, Hradec Králové
Krajska nemocnice Liberec, Liberec
Nemocnice Nove Mesto na Morave, Nové Město na Moravě
Fakultni poliklinika VFN, Prague
Vseobecna fakultni nemocnice v Praze, Prague
Pharmaceutical Research Associates CZ, s.r.o., Prague
Vilnius University Hospital Santariskiu Clinic, Public Institution, Centre of Nephrology, Vilnius
Zaklad Diagnostyki Chorob Serca, II Katedra Kardiologii, Gdansk
Klinika Nefrologii, Transplantologii i Chorob Wewnetrznych, Gdansk
Specjalistyczny Szpital Zachodni im. Jana Pawla II w Grodzisku Mazowieckim, Grodzisk Mazowiecki
Krakowskie Centrum Medyczne NZOZ, Krakow
Klinika Nefrologii, Hipertensjologii i Chorob Wewnetrznych Katedry Chorob Wewnetrznych UWM, Olsztyn
Pracownia Echokardiografii, Oddzial Kardiologii, Olsztyn
Centrum Medyczne Aesculap, Radom
Klinika Kardiologii, Szczecin
Klinika Nefrologii, Transplantologii i Chorob Wewnetrznych, Szczecin
Szpital Powiatowy w Wolominie, Wołomin
SPZOZ Akademicki Szpital Kliniczny im. J. Mikulicza - Radeckiego, Wroclaw
Institutul Clinic Fundeni, Centrul de Medicina Interna-Nefrologie, Bucharest
SUMMIT CLINICAL RESEARCH, s.r.o., Oddelenie internej mediciny a klinickej farmakologie, Bratislava
Seoul National University Hospital, Department of Internal Medicine, Seoul
Samsung Medical Center/Division of Nephrology, Seoul
Eulji General Hospital, Seoul
Hospital Universitari de Bellvitge, L'Hospitalet de Llobregat
Hospital Clinic I Provincial de Barcelona, Barcelona
Sahlgrenska Universitetssjukhuset, Njurmedicin, Gothenburg
Karolinska Universitetssjukhuset Huddinge, Stockholm
Karolinska Universitetssjukhuset Solna, Stockholm
Morriston Hospital, Swansea
BHF Glasgow Cardiovascular Research Centre, University of Glasgow, Glasgow
Renal and Urology Directorate, Leicester General Hospital, Leicester
Lead Sponsor
Pfizer
INDUSTRY